Mark Christopher Murray - 26 Feb 2025 Form 4 Insider Report for Celanese Corp (CE)

Reporting relationship: SVP - Acetyls
Issuer ticker: CE
Reported as of: 26 Feb 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 28 Feb 2025, 17:31:45 UTC
Prior SEC filing: 19 Feb 2025
Next SEC filing: 10 Mar 2025
Source filing: View source filing
Reporting owner signature: /s/ Blake Feikema, Attorney-in-Fact for Mark Christopher Murray

Key filing fact

Mark Christopher Murray filed Form 4 for Celanese Corp (CE) on 28 Feb 2025.

Key facts

This page summarizes Mark Christopher Murray's Form 4 filing for Celanese Corp (CE).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 28 Feb 2025, 17:31.

Change

Previous filing in this sequence was filed on 19 Feb 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CE transaction Derivative

Nonqualified Stock Option (right to buy)

Award

Transaction value: $0
Shares: +19,027
Change %
Price: $0.000000
Shares after: 19,027
Date: 26 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 19,027
Exercise price: $53.96
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Time-based employee stock options granted under the Company's 2018 Global Incentive Plan, as amended.

Footnote F2

The options vest and become exercisable, subject to continued employment, in three annual installments of 33%, 33% and 34% beginning February 15, 2026.